Corporate Announcement
Security Code : 524804    Company : AUROPHARMA    
 
Clarification On Reporting Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Ref : E-Mail Dated October 11, 2019 Received From BSE
Download PDF Download XBRL
  Exchange Received Time  11/10/2019 15:11:59         Exchange Disseminated Time   11/10/2019 15:12:05              Time Taken   00:00:06
Further to the clarification sought by you on Unit-7 facility inspection by USFDA and issue of Form 483 with 7 observations, we inform that these observations have no impact on the existing business with respect to the operations and revenues. Hence, no disclosure was made earlier.

The Company will be sending responses to the observations within the stipulated time to the regulatory authority.

 

Disclaimer

Back To Announcements